p.95 抽出テキスト

479. Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol 2022;79:933–46. https://doi.org/10. 1016/j.jacc.2022.01.018 480. van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation 2017;136:e232–68. https://doi.org/10.1161/CIR.0000000000000525 481. Zeymer U, Bueno H, Granger CB, Hochman J, Huber K, Lettino M, et al. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the Acute Cardiovascular Care Association of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care 2020;9:183–97. https://doi.org/10.1177/2048872619894254 482. Waksman R, Pahuja M, van Diepen S, Proudfoot AG, Morrow D, Spitzer E, et al. Standardized definitions for cardiogenic shock research and mechanical circulatory support devices: scientific expert panel from the Shock Academic Research Consortium (SHARC). Circulation 2023;148:1113–26. https://doi. org/10.1161/CIRCULATIONAHA.123.064527 483. Patel SM, Berg DD, Bohula EA, Baird-Zars VM, Park JG, Barnett CF, et al. Continuum of preshock to classic cardiogenic shock in the Critical Care Cardiology Trials Network Registry. JACC Heart Fail 2024;12:1625–35. https://doi.org/10.1016/j.jchf.2024.06.009 484. Jentzer JC, Burstein B, Van Diepen S, Murphy J, Holmes DR Jr, Bell MR, et al. Defining shock and preshock for mortality risk stratification in cardiac intensive care unit patients. Circ Heart Fail 2021;14:e007678. https://doi.org/10. 1161/CIRCHEARTFAILURE.120.007678 485. van Diepen S, Poss J, Senaratne JM, Gage A, Morrow DA. Mixed cardiogenic shock: a proposal for standardized classification, a hemodynamic definition, and framework for management. Circulation 2024;150:1459–68. https:// doi.org/10.1161/CIRCULATIONAHA.124.069508 486. Lee DS, Straus SE, Farkouh ME, Austin PC, Taljaard M, Chong A, et al. Trial of an intervention to improve acute heart failure outcomes. N Engl J Med 2023; 388:22–32. https://doi.org/10.1056/NEJMoa2211680 487. Miro O, Rossello X, Gil V, Martin-Sanchez FJ, Llorens P, Herrero-Puente P, et al. Predicting 30-day mortality for patients with acute heart failure in the emergency department: a cohort study. Ann Intern Med 2017;167: 698–705. https://doi.org/10.7326/M16-2726 488. Blumer V, Hanff TC, Gage A, Schrage B, Kanwar MK. Cardiogenic shock teams: past, present, and future directions. Circ Heart Fail 2025;18: e011630. https://doi.org/10.1161/CIRCHEARTFAILURE.124.011630 489. Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023; 44:3948–4042. https://doi.org/10.1093/eurheartj/ehad193 490. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020;41:543–603. https://doi.org/ 10.1093/eurheartj/ehz405 491. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720–826. https://doi.org/10.1093/eurheartj/ehad191 492. Voors AA, Angermann CE, Teerlink JR, Collins SP, Kosiborod M, Biegus J, et al. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med 2022;28:568–74. https://doi.org/10.1038/s41591-021-01659-1 493. Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, et al. Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial. JAMA Cardiol 2017;2:950–8. https:// doi.org/10.1001/jamacardio.2017.2198 494. Metra M, Adamo M, Tomasoni D, Mebazaa A, Bayes-Genis A, Abdelhamid M, et al. Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: a scientific statement by the Heart Failure Association of the ESC. Eur J Heart Fail 2023;25:1115–31. https://doi.org/ 10.1002/ejhf.2888 495. Tomasoni D, Davison B, Adamo M, Pagnesi M, Mebazaa A, Edwards C, et al. Safety indicators in patients receiving high-intensity care after hospital admission for acute heart failure: the STRONG-HF trial. J Card Fail 2024;30: 525–37. https://doi.org/10.1016/j.cardfail.2023.09.002 496. Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J, et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 2020; 396:1895–904. https://doi.org/10.1016/S0140-6736(20)32339-4 497. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006;296: 2217–26. https://doi.org/10.1001/jama.296.18.2217 498. Jobs A, Rausch TK, Konig IR, Vonthein R, Devendra A, Schafer J, et al. Inferior vena cava ultrasound to guide decongestion in acute decompensated heart failure: a randomized controlled trial. JACC Heart Fail 2025;13:102578. https://doi.org/10.1016/j.jchf.2025.102578 499. Thomas A, van Diepen S, Beekman R, Sinha SS, Brusca SB, Alviar CL, et al. Oxygen supplementation and hyperoxia in critically ill cardiac patients: from pathophysiology to clinical practice. JACC Adv 2022;1:100065. https://doi.org/10.1016/j.jacadv.2022.100065 500. Grensemann J, Fuhrmann V, Kluge S. Oxygen treatment in intensive care and emergency medicine. Dtsch Arztebl Int 2018;115:455–62. https://doi.org/ 10.3238/arztebl.2018.0455 501. Sepehrvand N, Ezekowitz JA. Oxygen therapy in patients with acute heart failure: friend or foe? JACC Heart Fail 2016;4:783–90. https://doi.org/10. 1016/j.jchf.2016.03.026 502. Weng CL, Zhao YT, Liu QH, Fu CJ, Sun F, Ma YL, et al. Meta-analysis: noninvasive ventilation in acute cardiogenic pulmonary edema. Ann Intern Med 2010;152:590–600. https://doi.org/10.7326/0003-4819-152-9- 201005040-00009 503. Gray A, Goodacre S, Newby DE, Masson M, Sampson F, Nicholl J, et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 2008;359:142–51. https://doi.org/10.1056/NEJMoa0707992 504. Rasoul D, Zhang J, Farnell E, Tsangarides AA, Chong SC, Fernando R, et al. Continuous infusion versus bolus injection of loop diuretics for acute heart failure. Cochrane Database Syst Rev 2024;5:CD014811. https://doi.org/10. 1002/14651858.CD014811.pub2 505. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011;364:797–805. https://doi.org/10.1056/NEJMoa1005419 506. Emmens JE, Ter Maaten JM, Matsue Y, Figarska SM, Sama IE, Cotter G, et al. Worsening renal function in acute heart failure in the context of diuretic response. Eur J Heart Fail 2022;24:365–74. https://doi.org/10.1002/ejhf.2384 507. Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 2012;5:54–62. https://doi.org/10.1161/CIRCHEARTFAILURE. 111.963413 508. Ter Maaten JM, Beldhuis IE, van der Meer P, Krikken JA, Postmus D, Coster JE, et al. Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial. Nat Med 2023;29:2625–32. https://doi.org/10.1038/ s41591-023-02532-z 509. Dauw J, Charaya K, Lelonek M, Zegri-Reiriz I, Nasr S, Paredes-Paucar CP, et al. Protocolized natriuresis-guided decongestion improves diuretic response: the multicenter ENACT-HF study. Circ Heart Fail 2024;17: e011105. https://doi.org/10.1161/CIRCHEARTFAILURE.123.011105 510. Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, et al. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 2022;387:1185–95. https://doi.org/10.1056/NEJMoa2203094 511. Trullas JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, Sanchez-Marteles M, Conde-Martel A, et al. Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J 2023;44:411–21. https://doi.org/10.1093/eurheartj/ehac689 512. Biegus J, Cotter G, Metra M, Ponikowski P. Decongestion in acute heart failure: is it time to change diuretic-centred paradigm? Eur J Heart Fail 2024;26: 2094–106. https://doi.org/10.1002/ejhf.3423 513. Biegus J, Mebazaa A, Davison B, Cotter G, Edwards C, Celutkiene J, et al. Effects of rapid uptitration of neurohormonal blockade on effective, sustainable decongestion and outcomes in STRONG-HF. J Am Coll Cardiol 2024;84: 323–36. https://doi.org/10.1016/j.jacc.2024.04.055 514. Biegus J, Voors AA, Collins SP, Kosiborod MN, Teerlink JR, Angermann CE, et al. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J 2023;44:41–50. https://doi.org/10.1093/ eurheartj/ehac530 515. Girerd N, Mewton N, Tartiere JM, Guijarro D, Jourdain P, Damy T, et al. Practical outpatient management of worsening chronic heart failure. Eur J Heart Fail 2022;24:750–61. https://doi.org/10.1002/ejhf.2503 516. Rasoul D, Chattopadhyay I, Mayer T, West J, Stollar H, Black C, et al. Economic evaluation of the Liverpool heart failure virtual ward model. Eur Downloaded from academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag100/8766302 by guest on 31 August 2026